Friday, December 5, 2025
Search

Catalyst Pharmaceuticals And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Via News Editorial Team

November 13, 2022

Catalyst Pharmaceuticals  And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Catalyst Pharmaceuticals (CPRX), The First Bancshares (FBMS), Allied Motion Technologies (AMOT) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Catalyst Pharmaceuticals (CPRX)

54.1% sales growth and 22.59% return on equity

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical firm at the commercial stage. It specializes in developing and marketing therapies for patients with neurological, debilitating, or chronic neuromuscular diseases. Firdapse is an amifampridine-phosphate tablet for patients suffering from lambert–eaton syndrome (LEMS). Ruzurgi can be used to treat LEMS children. Firdapse is also developed by the company to treat MuSK antibody positive myasthenia Gravis and spinal muscular atrophy Type 3. It can also be used to treat hereditary nervepathy with liability for pressure palsies. Endo Ventures Limited and BioMarin Pharmaceutical Inc. have license agreements. Endo Ventures Limited has a collaboration agreement for the commercialization and development of generic Sabril tablets. Catalyst Pharmaceutical Partners, Inc. was the company's former name. It changed its name in May 2015 to Catalyst Pharmaceuticals, Inc. Catalyst Pharmaceuticals, Inc., was established in 2002. It is located in Coral Gables, Florida.

Earnings per Share

Catalyst Pharmaceuticals' trailing 12 month EPS is $0.71.

PE Ratio

Catalyst Pharmaceuticals' trailing 12 months earnings to price ratio is 20.63 The purchaser of the shares is therefore investing $20.63 per dollar in annual earnings.

For the 12 trailing months, the company's return-on-equity, which is a measure of the profitability of a company relative to shareholders' equity, was 22.59%.

Sales Growth

Catalyst Pharmaceuticals has a 56.2% quarter-over-quarter sales increase and 54.1% in the following.

Yearly Top and Bottom Value

Catalyst Pharmaceuticals's stock is valued at $14.65 at 19:22 EST, way under its 52-week high of $17.22 and way higher than its 52-week low of $5.24.

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is 54.5% and 80%, respectively.

2. The First Bancshares (FBMS)

24.4% sales growth and 10.57% return on equity

The First Bancshares, Inc. operates as the bank holding company for The First, A National Banking Association that provides general commercial and retail banking services. The company operates through three segments: Commercial/Retail Bank, Mortgage Banking Division, and Holding Company. It offers deposit services, including checking, NOW, and savings accounts; other time deposits, such as daily money market accounts and longer-term certificates of deposit; and individual retirement and health savings accounts. The company also provides commercial loans comprising secured and unsecured loans for working capital, business expansion, and purchase of equipment and machinery; consumer loans consisting of equity lines of credit, as well as secured and unsecured loans for financing automobiles, home improvements, education, and personal investments; and real estate construction and acquisition loans. In addition, it originates loans to purchase existing residential homes or construct new homes, and to refinance existing mortgages; and provides financial and wealth management services. Further, the company offers internet banking services, automated teller machines, voice response telephone inquiry services, commercial sweep accounts, cash management services, safe deposit boxes, merchant, mobile deposit, direct deposit of payroll and social security checks, automatic drafts for various accounts, and credit card services. It primarily serves small to medium-sized businesses, professional concerns, individuals, associations, organizations, and governmental authorities. As of December 31, 2021, the company operated 90 locations in Mississippi, Alabama, Florida, Georgia, and Louisiana. The First Bancshares, Inc. was incorporated in 1995 and is headquartered in Hattiesburg, Mississippi.

Earnings Per Share

As for profitability, The First Bancshares has a trailing twelve months EPS of $2.85.

PE Ratio

The First Bancshares has a trailing twelve months price to earnings ratio of 11.38. Meaning, the purchaser of the share is investing $11.38 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 10.57%.

3. Allied Motion Technologies (AMOT)

20.6% sales growth and 8.39% return on equity

Allied Motion Technologies Inc., together with its subsidiaries, designs, manufactures, and sells precision and specialty controlled motion components and systems that are used in a range of industries worldwide. The company offers brush and brushless DC motors, brushless servo and torque motors, coreless DC motors, integrated brushless motor-drives, gearmotors, gearing, modular digital servo drives, motion controllers. It also provides electric steering actuators, steering motors, electrohydraulic pump motor, steering wheel sensor, traction wheel drives, power differentiating transaxles, incremental and absolute optical encoders, active and passive filters for power quality and harmonic issues, and other controlled motion-related products. The company sells its products to end customers and original equipment manufacturers in vehicle, medical, aerospace and defense, and industrial markets through direct sales force, as well as authorized manufacturers' representatives, agents, and distributors. Allied Motion Technologies Inc. was incorporated in 1962 and is headquartered in Amherst, New York.

Earnings per Share

Allied Motion Technologies' trailing 12 month EPS is $0.97.

PE Ratio

Allied Motion Technologies' trailing 12-month price-earnings ratio is 32.64. The purchaser of the shares is therefore investing $32.64 per dollar in annual earnings.

For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 8.39%.

Annual Top and Bottom Value

Allied Motion Technologies stock was valued at $31.66 as of 19:22 EST. This is way lower than its 52 week high of $44.70, and much higher than its 52-week lowest of $21.14.

Moving Average

Allied Motion Technologies's worth is above its 50-day moving average of $30.31 and above its 200-day moving average of $29.16.

Dividend Yield

Morningstar, Inc. claims that the next dividend payment will be made on November 15, 2022. The forward dividend rate and forward dividend yield are 0.1 and 0.32%, respectively.

Volume

The last volume reported by Allied Motion Technologies was 45457, which is 13.8% more than its average volume (40162).

4. Lattice Semiconductor Corporation (LSCC)

19.5% sales growth and 32.62% return on equity

Lattice Semiconductor Corporation, together with its subsidiaries, develops and sells semiconductor products in Asia, Europe, and the Americas. The company offers field programmable gate arrays that consist of four product families, including the Certus-NX and ECP, MachXO, iCE40, and CrossLink. It also provides video connectivity application specific standard products. In addition, the company licenses its technology portfolio through standard IP and IP core licensing, patent monetization, and IP services. It sells its products directly to end customers, and indirectly through a network of independent manufacturers' representatives and independent distributors. The company primarily serves original equipment manufacturers in the communications and computing, consumer, and industrial and automotive end markets. Lattice Semiconductor Corporation was incorporated in 1983 and is headquartered in Hillsboro, Oregon.

Earnings Per Share

As for profitability, Lattice Semiconductor Corporation has a trailing twelve months EPS of $0.34.

PE Ratio

Lattice Semiconductor Corporation has a trailing twelve months price to earnings ratio of 178.06. Meaning, the purchaser of the share is investing $178.06 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 32.62%.

5. CME Group (CME)

8.2% sales growth and 10.68% return on equity

CME Group Inc. and its affiliates operate contract markets worldwide for futures trading. Futures and options products are offered based on foreign exchange rates, interest rates, equityindices, foreign currency, agricultural commodities and energy. Fixed income products also available. Clearing house services include clearing, settling and guaranteeing options and futures contracts; cleared swaps products traded on its exchanges; trade processing, risk mitigation and other services. The company also offers market data services that include historical and real-time data. The company serves professionals traders, banks, individual and institutional investors, corporates, as well as manufacturers, suppliers, government, central and local governments. CME Group Inc. was formerly Chicago Mercantile Exchange Holdings Inc. CME Group Inc. was established in 1898. It is located in Chicago, Illinois.

Earnings per Share

CME Group's trailing 12 months EPS is $5.33.

PE Ratio

CME Group's trailing 12-month price-earnings ratio is 32.81. The purchaser of the shares is therefore investing $32.81 per dollar in annual earnings.

For the 12 trailing months, the company's return-on-equity, which is a measure of the business' profitability relative to shareholders' equity, was 10.68%.

Sales Growth

CME Group's sales growth for the next quarter is 8.2%.

Moving Average

CME Group's stock value falls below its 50-day moving mean of $181.93, and well below its 200-day moving mean of $208.76.

Previous days news about CME Group(CME)

  • According to FXStreet on Friday, 11 November, "Following the release, the CME Group FedWatch Tool showed that markets are pricing in an 80% probability of a 50 basis points rate hike in December, compared to 52% just before the release. "
  • According to FXStreet on Friday, 11 November, "Considering advanced prints from CME Group for natural gas futures markets, open interest added to the previous build and went up by more than 1K contracts on Thursday. "
  • According to FXStreet on Friday, 11 November, "With both of these readings coming in below market expectations, the CME Group FedWatch Tool's probability of a 50 basis points Fed rate hike in December jumped above 80% from 50% earlier in the week. "

6. Gildan Activewear (GIL)

5.1% sales growth and 37.2% return on equity

Gildan Activewear Inc. produces and markets a variety of apparel products throughout North America, Europe and the Asia-Pacific. It manufactures and sells activewear products including fleece tops and bottoms as well as T-shirts and sports shirts. The company also sells hosiery such as athletic, casual, workwear and liner hosiery. The company also offers men's and women's tops and bottoms underwear under Gildan Platinum and Gildan Platinum brands; as well as ladies' shapewear and intimates under Secret Silky and Secret Silky. It offers its products through wholesale distributors, screen printers/embellishers, and retailers, as well as through its e-commerce platforms. The original name of the company was Textiles Gildan Inc., but it changed its name in March 1995 to Gildan Activewear Inc. Gildan Activewear Inc. is located in Montreal, Canada. It was founded in 1984.

Earnings Per Share

As for profitability, Gildan Activewear has a trailing twelve months EPS of $-1.14.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 37.2%.